More Clinical Articles


3 Questions to Joel Beetsch, Vice President of Patient Advocacy, Celgene

Nick de Cent, (Aug 29, 2014)

eyeforpharma asked Joel Beetsch, Vice President of Patient Advocacy at Celgene, 3 questions about how patient centricity is changing the landscape of clinical trials.

Why drugs fail to get approved

Zuzanna Fimińska, (Aug 25, 2014)

Over 12 years, 50%new molecular entities (NMEs) failed to obtain approval when first submitted to the FDA. Some new applications were rejected because of inadequate drug performance, other, however, failed because of, what looks at first glance as, sloppiness.

Using Data to Design and Implement Patient-Centric Enrollment and Retention Strategies

Scott Connor, (Aug 22, 2014)

What sponsor doesn’t want more successful clinical trials – on time, on budget, with quality data?

Can we harness “big data” effectively?

Nick de Cent, (Aug 13, 2014)

From new healthcare products to the way we conduct clinical trials, “big data” is poised to transform the pharma landscape. But first, we’ve got to work out how to use it effectively – especially in the best interests of the patient, writes Nick de Cent.

Empowering Patients

Ulrich Neumann, (Aug 5, 2014)

The need for disruptive innovation in pharma has reached a precipice. In order to compete in the era of stratified medicine, cost-effectiveness considerations, and overall patient empowerment, the industry must rethink every aspect of the drug development continuum.

Some Front Row Perspectives on Patient Centricity

Paul Ivsin, (Aug 4, 2014)

"And that is quite likely the biggest barrier to advocates of patient centered clinical trials today: not that they will be resisted, but that their message will be co-opted and their efforts shunted into high-visibility but low-impact initiatives".

The Patient Centricity “Fad” and the Token Patient

Paul Ivsin, (Jul 30, 2014)

Embracing the concept of patient centricity does not guarantee substantial patient-centred change, particularly in the area of patient-centred trials.

Management of Patient Adherence in Clinical Trials Using Electronic Monitoring

John Musaus, (Jul 25, 2014)

Automatic adherence measurement through electronic compilation of drug dosing histories plays a key role in achieving and maintaining patients’ adherence to prescribed therapies.

Which Patients Are We Centred On?

Paul Ivsin, (Jul 24, 2014)

Paul Ivsin explains how our attempts to make clinical trials more patient-friendly have, for the most part, been subverted by the need to collect more comprehensive and more patient-relevant data, which can prove burdensome to the patient.

Digitization on trial

Nick de Cent, (Jul 18, 2014)

Clinical trials represent one important area where digitization is set to transform the pharma landscape, as social networks bring faster and more targeted recruitment of participants, writes Nick de Cent.